Objective: The aims of this study were to examine the prognostic value of SHP-1 in breast cancer, its roles in the regulation of breast cancer cell growth and metastasis, and the underlying mechanisms. Methods: Tumor specimens from 160 patients with breast cancer and 160 noncancerous tissues were used to examine the expression of SHP-1 and to analyze its association with overall survival through Kaplan–Meier and multivariate Cox regression analyses. RNA sequencing data and the expression and clinical importance of SHP-1 in breast cancer were evaluated with data from The Cancer Genome Atlas. In vitro and in vivo assays were performed to elucidate the effects of SHP-1 on breast cancer cell proliferation and invasion. Confocal immunofluorescence and GST pulldown assays were used to demonstrate the interaction between SHP-1 and epidermal growth factor receptor, as well as its downstream pathways. Immunohistochemistry and The Cancer Genome Atlas database were used to investigate the clinical association between SHP-1 and EGFR in human breast cancer. Results: SHP-1 expression was associated with better survival in patients with breast cancer, whereas SHP-1 expression was negatively correlated with EGFR in human breast cancer. Ectopic SHP-1 expression significantly suppressed breast cancer cell proliferation, migration, and invasion. SHP-1 knockdown induced a more invasive phenotype and accelerated cell growth. Mechanistically, EGFR, a protein directly interacting with SHP-1, mediates the SHP-1-induced inactivation of Ras/Erk/GSK3β signaling and its downstream effectors. Conclusions: SHP-1 is an important prognostic biomarker in patients with breast cancer, and the SHP-1-EGFR axis is a promising target for treatment.

Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;Cancer Center, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China;Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, China

[1]Qian Geng;Ruiting Xian;Yinjue Yu;Fengsheng Chen;Rong Li-.SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer)[J].癌症生物学与医学（英文版）,2022(04):468-485

noncancerous

SHP,acts,tumor,suppressor,by,interacting,EGFR,predicts,prognosis,human,breast,Objective,aims,this,study,were,examine,prognostic,value,its,roles,regulation,cell,growth,metastasis,underlying,mechanisms,Methods,Tumor,specimens,from,patients,tissues,used,expression,analyze,association,overall,survival,through,Kaplan,Meier,multivariate,Cox,regression,analyses,sequencing,clinical,importance,evaluated,Cancer,Genome,Atlas,In,vitro,vivo,assays,performed,elucidate,effects,proliferation,invasion,Confocal,immunofluorescence,GST,pulldown,demonstrate,interaction,between,epidermal,receptor,well,downstream,pathways,Immunohistochemistry,database,investigate,Results,was,associated,better,whereas,negatively,correlated,Ectopic,significantly,suppressed,migration,knockdown,induced,more,invasive,phenotype,accelerated,Mechanistically,protein,directly,mediates,inactivation,Ras,Erk,GSK3,signaling,effectors,Conclusions,important,biomarker,axis,promising,target,treatment

0.491241